Response to Chemotherapy in Mesothelioma Patients: Could This Protein Predict It?
There is new evidence that a protein called Activin A could help predict response to chemotherapy in patients with malignant pleural mesothelioma. It may also make it easier for doctors to distinguish mesothelioma from benign lung tumors. Activin A influences many cellular processes. Among other things, it plays a role in cell proliferation, immune response, metabolism, and natural cell death. FInnish researchers say mesothelioma patients with higher levels of Activin A in their blood are more likely to suffer from cachexia. Cachexia is weakness and wasting of the body due to chronic illness. High expressors of Activin A are also less likely to have a good response to chemotherapy. Activin A and Mesothelioma Activin A is a member of the … Continue reading Response to Chemotherapy in Mesothelioma Patients: Could This Protein Predict It?
Get your free copy of
“Surviving Mesothelioma” Today!